• Je něco špatně v tomto záznamu ?

Adverse drug reactions: analysis of spontaneous reporting system in Europe in 2007-2009

J. Srba, V. Descikova, J. Vlcek,

. 2012 ; 68 (7) : 1057-63.

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13000963
E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do Před 1 rokem
CINAHL Plus with Full Text (EBSCOhost) od 2008-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 1997-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do Před 1 rokem

PURPOSE: Spontaneous reporting systems in European countries are crucial for collecting adverse drug reaction (ADR) reports. The aim of this study was to evaluate reporting activity among countries and their strategy to increase the number of reports. We also established the best measure for assessment quantity of reports. METHODS: This was a retrospective observational study based on questionnaires and annual reports. The most reliable measure of reporting was determined by Spearman correlation coefficients. RESULTS: Data collected in spontaneous reporting systems in 26 European countries were analysed. In 2007, 2008 and 2009, the average value of reports per year per million inhabitants based on the safety databases of countries was 208, 236, 286, respectively; in comparison, that of Eudra- Vigilance was 311, 453 and 435, respectively. Twelve countries reached a significant level for signal detection of ADRs in 2009. The population-based reporting ratio (PBRR) was correlated to the total expenditure on health (ρ=0.499, p=0.023, n=21), public expenditure on health (ρ=0.477, p=0.035, n=20), density of physicians (ρ=0.336, p=0.136, n=21) and expenditure on pharmaceuticals (ρ=0.365, p=0.114, n=20). Strategies of regulatory authorities to increase reporting were determined. CONCLUSIONS: The results of this study make several noteworthy contributions regarding national spontaneous reporting systems. The relevance of the PBRR for the measurement reporting activity is clearly supported by the current findings. This study also shows that there is a general trend towards increased reporting activity. This is maintained by regional centres and encouragement of reporting. A further study would be helpful to assess the effectiveness of reporting systems at both the national and European level.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13000963
003      
CZ-PrNML
005      
20240104144039.0
007      
ta
008      
130108s2012 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00228-012-1219-4 $2 doi
035    __
$a (PubMed)22294060
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Srba, Jindrich $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University, Hradec Kralove, Czech Republic. jindrich.srba@gmail.com
245    10
$a Adverse drug reactions: analysis of spontaneous reporting system in Europe in 2007-2009 / $c J. Srba, V. Descikova, J. Vlcek,
520    9_
$a PURPOSE: Spontaneous reporting systems in European countries are crucial for collecting adverse drug reaction (ADR) reports. The aim of this study was to evaluate reporting activity among countries and their strategy to increase the number of reports. We also established the best measure for assessment quantity of reports. METHODS: This was a retrospective observational study based on questionnaires and annual reports. The most reliable measure of reporting was determined by Spearman correlation coefficients. RESULTS: Data collected in spontaneous reporting systems in 26 European countries were analysed. In 2007, 2008 and 2009, the average value of reports per year per million inhabitants based on the safety databases of countries was 208, 236, 286, respectively; in comparison, that of Eudra- Vigilance was 311, 453 and 435, respectively. Twelve countries reached a significant level for signal detection of ADRs in 2009. The population-based reporting ratio (PBRR) was correlated to the total expenditure on health (ρ=0.499, p=0.023, n=21), public expenditure on health (ρ=0.477, p=0.035, n=20), density of physicians (ρ=0.336, p=0.136, n=21) and expenditure on pharmaceuticals (ρ=0.365, p=0.114, n=20). Strategies of regulatory authorities to increase reporting were determined. CONCLUSIONS: The results of this study make several noteworthy contributions regarding national spontaneous reporting systems. The relevance of the PBRR for the measurement reporting activity is clearly supported by the current findings. This study also shows that there is a general trend towards increased reporting activity. This is maintained by regional centres and encouragement of reporting. A further study would be helpful to assess the effectiveness of reporting systems at both the national and European level.
650    _2
$a systémy pro sběr zpráv o nežádoucích účincích léků $x organizace a řízení $x statistika a číselné údaje $x trendy $7 D016907
650    _2
$a sběr dat $7 D003625
650    _2
$a databáze faktografické $7 D016208
650    _2
$a zapojení pacienta $x metody $7 D010358
650    _2
$a farmakovigilance $7 D060735
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Deščíková, Veronika $7 xx0312300
700    1_
$a Vlcek, Jiri
773    0_
$w MED00001613 $t European journal of clinical pharmacology $x 1432-1041 $g Roč. 68, č. 7 (2012), s. 1057-63
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22294060 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130108 $b ABA008
991    __
$a 20240104144033 $b ABA008
999    __
$a ok $b bmc $g 963745 $s 799127
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 68 $c 7 $d 1057-63 $i 1432-1041 $m European journal of clinical pharmacology $n Eur J Clin Pharmacol $x MED00001613
LZP    __
$a Pubmed-20130108

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...